Does Dr. JOSE FOURNIER REBOLLO have financial conflicts of interest?

Dr. JOSE FOURNIER REBOLLO (M.D.) has received a total of $1,493 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,493 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JOSE FOURNIER REBOLLO?

According to CMS Open Payments data, Dr. JOSE FOURNIER REBOLLO received funding from FERRING PHARMACEUTICALS ($532), VERITY PHARMACEUTICALS ($365), and BOSTON SCIENTIFIC CORPORATION ($262).

Does Dr. JOSE FOURNIER REBOLLO receive research grants or speaking fees?

Dr. JOSE FOURNIER REBOLLO has received $1,493 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JOSE FOURNIER REBOLLO

M.D.Real-Time Hydrated

Specialty: Urology

Practice Location: SAN JUAN, PR 00926

NPI Number: 1750484143

LIFETIME INDUSTRY VALUE

$1,493

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. FOURNIER REBOLLO is a verified Urology practitioner based in SAN JUAN, PR.

Between 2021 and 2025, Dr. FOURNIER REBOLLO had an overall industry promotional and research financial footprint of $1,493 as recorded in the federal CMS Open Payments database.

$1,493 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. FOURNIER REBOLLO's primary funding source is FERRING PHARMACEUTICALS, which accounts for $532 (representing 35.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

FERRING PHARMACEUTICALS

Rank 1

$532

35.6%

VERITY PHARMACEUTICALS

Rank 2

$365

24.4%

BOSTON SCIENTIFIC CORPORATION

Rank 3

$262

17.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.